Recruiting NCT05387304
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: COVID-19. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study is to clarify the distribution characteristics, host and clinical characteristics, disease outcome and risk factors, changes of multiple organs such as cardiopulmonary function and changes in social and psychological indicators during long-term follow-up of omicron variant asymptomatic infections and diagnosed patients
Primary outcome measures
- long-term outcomes，changes of clinical characteristic and social psychology [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- SARS-Cov-2-RNA positive
- informed consent signed
Exclusion criteria
- informed consent rejected
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Ruijin Hospital — Shanghai
Identifiers
NCT: NCT05387304 · SCAM2022-1